Patients Coming Off Weight-Loss Injections Regain Weight Four Times Faster Compared to Those on Conventional Diets

New research reveals that individuals who come off new slimming jabs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who stop conventional lifestyle plans.

Published data in a prominent medical journal shows that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"Users using such treatments should be cognizant of the potential of rapid rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

This pace of regain means a reversion to original mass in about a year and a half.

Comparing Approaches

The study, which looked at 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.

The team emphasize that individuals who shed pounds through dieting typically have a more gradual creep back—approximately 0.1 kg a month—after stopping.

Understanding the Rapid Rebound

Experts believe the mechanism of the injections explains the heightened regain.

GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement means hunger is no longer kept in check, making overeating a significant risk."

A Chronic Issue?

Health authorities recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts say that, given the high risk of weight regain, the therapy should be considered life-long.

This opinion is reinforced by drug manufacturers, who state that the results "underscore the long-term nature of obesity," similar to managing diseases like hypertension.

Patient Testimonies

People who have discontinued the medication explain a powerful resurgence of cravings.

"It was like something activating and I was suddenly extremely hungry," described an individual.

This difficulty is compounded if individuals have not developed lasting lifestyle or habit changes during treatment.

Growing Interest

Recent estimates indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.

• Use is higher among women than men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion obtain the medications through private healthcare rather than public health services.

Finally, experts stress that while the jabs are effective tools for weight loss, they are not a standalone solution and maintained weight loss likely depends on combined behavioural support.